These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 2449824
1. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. Johnson DE, Herndier BG, Medeiros LJ, Warnke RA, Rouse RV. Am J Surg Pathol; 1988 Mar; 12(3):187-97. PubMed ID: 2449824 [Abstract] [Full Text] [Related]
2. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma. Patsenker E, Wilkens L, Banz V, Osterreicher CH, Weimann R, Eisele S, Keogh A, Stroka D, Zimmermann A, Stickel F. J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822 [Abstract] [Full Text] [Related]
3. Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects. Fischer HP, Altmannsberger M, Weber K, Osborn M. Am J Pathol; 1987 Jun; 127(3):530-7. PubMed ID: 2438941 [Abstract] [Full Text] [Related]
4. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M. Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022 [Abstract] [Full Text] [Related]
5. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Ma CK, Zarbo RJ, Frierson HF, Lee MW. Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185 [Abstract] [Full Text] [Related]
6. Immunohistochemistry in the differential diagnosis of liver carcinomas. Hurlimann J, Gardiol D. Am J Surg Pathol; 1991 Mar; 15(3):280-8. PubMed ID: 1847609 [Abstract] [Full Text] [Related]
7. The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type. Akiba J, Nakashima O, Hattori S, Naito Y, Kusano H, Kondo R, Nakayama M, Tanikawa K, Todoroki K, Umeno Y, Nakamura K, Sanada S, Yamaguchi R, Ogasawara S, Yano H. J Clin Pathol; 2016 Oct; 69(10):846-51. PubMed ID: 26969740 [Abstract] [Full Text] [Related]
8. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma. Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR. Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797 [Abstract] [Full Text] [Related]
9. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Maeda T, Adachi E, Kajiyama K, Sugimachi K, Tsuneyoshi M. Hum Pathol; 1995 Sep; 26(9):956-64. PubMed ID: 7545644 [Abstract] [Full Text] [Related]
10. Evidence for a hepatocellular lineage in a combined hepatocellular-cholangiocarcinoma of transitional type. Fisher HP, Doppl W, Osborn M, Altmannsberger M. Virchows Arch B Cell Pathol Incl Mol Pathol; 1988 Sep; 56(2):71-6. PubMed ID: 2467436 [Abstract] [Full Text] [Related]
11. [Primary malignant neoplasms of the liver. Contribution of echography to the preoperative diagnosis]. Lovotti D, De Angelis G, Buonocore M, Belisomo M, Tinozzi S, Maucci A. Minerva Chir; 1989 Oct 15; 44(19):2059-64. PubMed ID: 2559363 [Abstract] [Full Text] [Related]
12. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma. Ramalho FS, Ramalho LN, Della Porta L, Zucoloto S. J Gastroenterol Hepatol; 2006 Aug 15; 21(8):1276-80. PubMed ID: 16872309 [Abstract] [Full Text] [Related]
13. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections. Balaton AJ, Nehama-Sibony M, Gotheil C, Callard P, Baviera EE. J Pathol; 1988 Dec 15; 156(4):305-10. PubMed ID: 2465399 [Abstract] [Full Text] [Related]
14. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas. Stroescu C, Herlea V, Dragnea A, Popescu I. J Gastrointestin Liver Dis; 2006 Mar 15; 15(1):9-14. PubMed ID: 16680226 [Abstract] [Full Text] [Related]
15. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7. Ramos-Vara JA, Miller MA, Johnson GC. Vet Pathol; 2001 Nov 15; 38(6):636-43. PubMed ID: 11732796 [Abstract] [Full Text] [Related]
16. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Leong AS, Sormunen RT, Tsui WM, Liew CT. Histopathology; 1998 Oct 15; 33(4):318-24. PubMed ID: 9822920 [Abstract] [Full Text] [Related]
17. [An immunohistochemical study on primary carcinoma of the liver]. Seo JK. J UOEH; 1989 Dec 01; 11(4):429-39. PubMed ID: 2481871 [Abstract] [Full Text] [Related]
18. Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas. Lai YS, Thung SN, Gerber MA, Chen ML, Schaffner F. Arch Pathol Lab Med; 1989 Feb 01; 113(2):134-8. PubMed ID: 2464975 [Abstract] [Full Text] [Related]
19. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma. Aishima S, Asayama Y, Taguchi K, Sugimachi K, Shirabe K, Shimada M, Sugimachi K, Tsuneyoshi M. Mod Pathol; 2002 Nov 01; 15(11):1181-90. PubMed ID: 12429797 [Abstract] [Full Text] [Related]
20. Blood-group-related antigen Lewis(x) and Lewis(y) in the differential diagnosis of cholangiocarcinoma and hepatocellular carcinoma. Jovanovic R, Jagirdar J, Thung SN, Paronetto F. Arch Pathol Lab Med; 1989 Feb 01; 113(2):139-42. PubMed ID: 2537068 [Abstract] [Full Text] [Related] Page: [Next] [New Search]